Transfer

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

T-cell engager antibodies

Transfer, New Research Findings, VIRO,

Bioengineering Meets Hepatitis B: Researchers Design Promising Novel Therapeutic Candidates

Researchers have designed antibodies as novel therapeutic candidates for the treatment of chronic hepatitis B and hepatocellular carcinoma. Their study in human cell cultures and in living mice showed the elimination of antigen-positive cells and…

Pancreatic organoids on newly developed chip platform

Transfer, New Research Findings, Pioneer Campus,

Researchers Engineer an Organoid on Chip Platform to Recapitulate Pancreatic Organoids

A newly engineered organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer. The study was carried out by an…

Medical concept of cancer. 3d illustration of T cells or cancer cells.

Transfer, New Research Findings, TOXI,

First-in-class Cancer Immunotherapy Drug in Clinical Trial

A small molecule has entered a novel clinical trial for cancer immunotherapy. The molecule inhibits an enzyme called MALT1 that plays a critical role in suppressing immune reactions against tumor cells. Preclinical studies showed that blocking MALT1…

Transfer und Netzwerke

Transfer,

Helmholtz Zentrum München and Novo Nordisk extended their research collaboration in metabolic diseases

Helmholtz Zentrum München and Novo Nordisk recently extended their multi-year strategic partnership which aims to identify and jointly develop novel targets and enabling technologies, ultimately supporting the development of innovative medicines for…

3D model Chagas protein blocking molecule

Transfer, Awards & Grants, Molecular Targets and Therapeutics, STB,

Helmholtz Zentrum München Is the Recipient of the 2020 Erwin Schrödinger Prize

Researchers at Helmholtz Zentrum München and the University of Bochum received this year's Erwin Schrödinger Prize in recognition of their efforts to develop a cure for parasitic diseases such as Chagas disease with a new compound. The prize is…

business and network

Transfer,

Research Cooperation between Helmholtz Zentrum München and Boehringer Ingelheim

The Helmholtz Zentrum München teams up with Boehringer Ingelheim in an endeavor to identify novel candidates for anti-obesity treatment.